Poland· PL-100002817
Addiphos
A electrolyte solutions product containing kalii dihydrogenophosphas + dinatrii phosphas dihydricus + kalii hydroxidum, registered in Poland by Fresenius Kabi AB. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Kalii dihydrogenophosphas + dinatrii phosphas dihydricus + kalii hydroxidum is registered in 2 of 19 countries.
Countries holding a registration under ATC B05XA (electrolyte solutions), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Kalii dihydrogenophosphas + dinatrii phosphas dihydricus + kalii hydroxidum · ATC B05XA
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Kalii dihydrogenophosphas + Dinatrii phosphas dihydricus + Kalii hydroxidum
- Manufacturer
- Fresenius Kabi AB
- Country
- Poland (PL)
- ATC code
- B05XA
- ATC class
- Electrolyte solutions
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990271719
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05XA
Electrolyte solutions, as other registers publish it.
- PolandAddiphosDelfarma Sp. z o.o.
- CzechiaGLUCOSE-1-PHOSPHATE FRESENIUS 1 MOLARFresenius Kabi Austria GmbH, Graz
- CzechiaGLUCOSE-1-PHOSPHATE FRESENIUS 1 MOLARFresenius Kabi Austria GmbH, Graz
- CzechiaGLUCOSE-1-PHOSPHATE FRESENIUS 1 MOLARFresenius Kabi s.r.o., Praha
- CzechiaGLUCOSE-1-PHOSPHATE FRESENIUS 1 MOLARFresenius Kabi s.r.o., Praha
- CzechiaGLUCOSE-1-PHOSPHATE FRESENIUS 1 MOLARFresenius Kabi Austria GmbH, Graz
- CzechiaGLUCOSE-1-PHOSPHATE FRESENIUS 1 MOLARFresenius Kabi s.r.o., Praha
- PolandGlycophosDelfarma Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3459e641-cd60-45fa-848d-18ee550aabef GET /v1/drugs/3459e641-cd60-45fa-848d-18ee550aabef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "(170,1 mg + 133,5 mg + 14 mg)/ml",
"packaging": "05909990271719 ¦ Lz ¦ 462\n10 fiol. 20 ml",
"substance": "Kalii dihydrogenophosphas 170.1 mg/ml + Dinatrii phosphas dihydricus 133.5 mg/ml + Kalii hydroxidum 14 mg/ml",
"common_name": "Kalii dihydrogenophosphas + Dinatrii phosphas dihydricus + Kalii hydroxidum",
"pl_product_id": "100002817",
"pozwolenie_nr": "02717",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about kalii dihydrogenophosphas + dinatrii phosphas dihydricus + kalii hydroxidum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.